SEO URLwww.firestrike.ai/deals/day-one-biopharma-servier-acquisition-2026-8
acquisitionAnnounced · Mar 6, 2026medicalSource · CredibleArticle · Factual
Servier acquires Day One Biopharma
David Najork · Founding Software Engineer
Published · Updated · 1 min read
Deal value
$2.5B
Target
Day One Biopharma
NASDAQ: DAWN · Brisbane, California
Acquirer
Servier
Full Acquisition
Status
Pending
Servier agreed to acquire Day One Biopharma. Reported deal value: $2.5B. Status: Pending. Sector: medical. Target headquarters context: Brisbane, California, United States.
This page summarizes publicly available information about the transaction as of 2026-03-06. Figures and status may change as filings and press coverage update.
Day One Biopharmaceuticals Agrees to Be Acquired by Servier for $2.5 billion Day One Biopharmaceuticals has agreed to be acquired by French pharmaceutical group Servier for $21.50 per share in cash, or a total equity value of about $2.5 billion , the companies said
Deal timeline
Announced
Mar 6, 2026 · uk.marketscreener.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in medical with a reported deal value of $2.5B. Figures and status may change as sources update.
Sources: uk.marketscreener.com · Primary article · FireStrike proprietary index